Ostermann
Dieter Ostermann, Dusseldorf DE
Patent application number | Description | Published |
---|---|---|
20080213641 | Photoelectrochemical Reaction Cell - The invention relates to a reaction cell for the photoelectrochemical production of hydrogen gas, comprising a housing which is filled with an aqueous electrolyte, a pair of electrodes consisting of a first electrode of a doped conductor which is immersed in the electrolytes and a second electrode which is made of metal and which is immersed in the electrolytes and which is electrically conductively connected to the first electrode, also comprising a light source which illuminates the pair of electrodes. The reaction cell is characterized in that the electrodes are connected to each other in a flat manner, the pair of electrodes divides the reaction cell into two chambers, wherein the chambers are connected to each other in a fluidically conducting manner and the housing is provided with at least one gas outlet. | 09-04-2008 |
Dieter Ostermann, Neuss DE
Patent application number | Description | Published |
---|---|---|
20100200047 | METHOD OF PRODUCING A THIN FILM PHOTOVOLTAIC SYSTEM, AND A THIN FILM PHOTOVOLTAIC SYSTEM - A method of producing a thin film photovoltaic system ( | 08-12-2010 |
20110232723 | LAYER SYSTEM FOR SOLAR ABSORBER - Solar absorber ( | 09-29-2011 |
20130192588 | Method and Device for Producing a Highly Selectively Absorbing Coating on a Solar Absorber Component and Solar Absorber Having Such Coating - The invention relates to a method for producing a selectively absorbing coating on a solar absorber component comprising the steps of: | 08-01-2013 |
Elinborg Ostermann, Vienna AT
Patent application number | Description | Published |
---|---|---|
20090304718 | Antibody Molecules Specific for Fibroblast Activation Protein and Immunoconjugates Containing Them - Anti-FAP-antibodies and immunoconjugates, pharmaceutical compositions containing such conjugates, and their use in cancer therapy. | 12-10-2009 |
20100189722 | ANTI CD37 ANTIBODIES - Chimeric and humanized anti-CD37 antibodies and pharmaceutical compositions containing them are useful for the treatment of B cell malignancies and autoimmune and inflammatory diseases that involve B cells in their pathology. | 07-29-2010 |
20100196395 | ANTI-IGF ANTIBODIES - Antibody molecules, in particular fully human antibodies that bind to human IGF-1 and cross-react with IGF-2 such that binding of IGF-1 and IGF-2 to the IGF-1 receptor is prevented and IGF-1 receptor-mediated signaling is inhibited. The antibodies do not bind to insulin and thus do not affect the mitogenic properties of insulin that are mediated by its binding to the insulin receptors. The antibodies are useful for the treatment of hyperproliferative diseases, in particular cancer. | 08-05-2010 |
20110165153 | ANTI CD37 ANTIBODIES - Chimeric and humanized anti-CD37 antibodies and pharmaceutical compositions containing them are useful for the treatment of B cell malignancies and autoimmune and inflammatory diseases that involve B cells in their pathology. | 07-07-2011 |
Elinborg Ostermann, Mauerbach AT
Patent application number | Description | Published |
---|---|---|
20140004110 | ANTI CD37 ANTIBODIES | 01-02-2014 |
20140010808 | ANTI CD37 ANTIBODIES - Chimeric and humanized anti-CD37 antibodies and pharmaceutical compositions containing them are useful for the treatment of B cell malignancies and autoimmune and inflammatory diseases that involve B cells in their pathology. | 01-09-2014 |
20160137729 | ANTI CD37 ANTIBODIES - Chimeric and humanized anti-CD37 antibodies and pharmaceutical compositions containing them are useful for the treatment of B cell malignancies and autoimmune and inflammatory diseases that involve B cells in their pathology. | 05-19-2016 |
Jason E. Ostermann, Plano, TX US
Patent application number | Description | Published |
---|---|---|
20090327733 | Data Security Method and System - A method of verifying integrity of a digital file includes receiving the digital file subsequent to exposure to a foreign environment and validating the digital file. The received digital file has an appended signature label that includes one or both of a first hash value and a digital signature. Validating the digital file includes hashing the digital file to obtain a second hash value, retrieving the first hash value from the signature label, and comparing the first hash value and second hash value. | 12-31-2009 |
Joachim B. Ostermann, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20100183630 | Tat-005 and Methods of Assessing and Treating Cancer - Surprisingly, the present inventors have discovered that expression of TAT-005 protein in human patients is associated with cancer, and that the over-expressed protein is present in plasma membrane fractions. Thus, the present inventors have discovered that TAT-005 is associated with abnormal development and growth, and may be useful as a target for the identification of anti-cancer com\ pounds, including antibodies for use in immunotherapy. Accordingly, the present invention provides methods for the identification of compounds that inhibit TAT-005 expression or activity, comprising: contacting a candidate compound with a TAT-005 and detecting the presence or absence of binding between said compound and said TAT-005, or detecting a change in TAT-005 expression or activity. Methods are also included for the identification of compounds that modulate TAT-005 expression or activity, comprising: administering a compound to a cell or cell population, and detecting a change in TAT-005 expression or activity. The methods of the invention are useful for the identification of anti-cancer compounds. | 07-22-2010 |
Joachim Bernhard Ostermann, Edmonton CA
Patent application number | Description | Published |
---|---|---|
20110305701 | Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases - The invention provides a method for treating a medical condition, disease, or disorder mediated by a misfolded form of superoxide dismutase (SOD) in a subject in need of treatment. The method optionally comprises administering to the subject a composition comprising a pharmaceutically acceptable vehicle and an agent selected from (1) an exogenous antibody or fragment thereof that binds selectively to the misfolded form of SOD, and/or (2) an immunogen that elicits production of an endogenous antibody that binds selectively to the misfolded form of SOD, and/or (3) a nucleic acid sequence encoding (1) or (2). In certain embodiments, the invention provides methods of treating diseases such as Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis using amyotrophic disease-specific epitopes, and compositions including these epitopes. The invention also provides antibodies that bind to monomeric or misfolded SOD1, and not on the molecular surface of native homodimeric SOD1. In addition, the invention includes methods of diagnosing Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis in a subject. Also, the invention provides methods of identifying substances for the treatment or prevention of Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis and kits using the binding proteins of the invention. | 12-15-2011 |
20140348822 | Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated DIseases - The invention provides a method for treating a medical condition, disease, or disorder mediated by a misfolded form of superoxide dismutase (SOD) in a subject in need of treatment. The method optionally comprises administering to the subject a composition comprising a pharmaceutically acceptable vehicle and an agent selected from (1) an exogenous antibody or fragment thereof that binds selectively to the misfolded form of SOD, and/or (2) an immunogen that elicits production of an endogenous antibody that binds selectively to the misfolded form of SOD, and/or (3) a nucleic acid sequence encoding (1) or (2). In certain embodiments, the invention provides methods of treating diseases such as Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis using amyotrophic disease-specific epitopes, and compositions including these epitopes. The invention also provides antibodies that bind to monomeric or misfolded SOD1, and not on the molecular surface of native homodimeric SOD1. In addition, the invention includes methods of diagnosing Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis in a subject. Also, the invention provides methods of identifying substances for the treatment or prevention of Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis and kits using the binding proteins of the invention. | 11-27-2014 |
Joachim Bernhard Ostermann, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20080206251 | Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases - The invention provides a method for treating a medical condition, disease, or disorder mediated by a misfolded form of superoxide dismutase (SOD) in a subject in need of treatment. The method optionally comprises administering to the subject a composition comprising a pharmaceutically acceptable vehicle and an agent selected from (1) an exogenous antibody or fragment thereof that binds selectively to the misfolded form of SOD, and/or (2) an immunogen that elicits production of an endogenous antibody that binds selectively to the misfolded form of SOD, and/or (3) a nucleic acid sequence encoding (1) or (2). In certain embodiments, the invention provides methods of treating diseases such as Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis and macular degeneration, glaucoma, ischemia, cerebral infarction, myocardial infarction, atherosclerosis, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease or necrotizing enterocolitis using disease-specific epitopes, and compositions including these epitopes. The invention also provides antibodies that bind to monomeric or misfolded SOD1, and not on the molecular surface of native homodimeric SOD1. In addition, the invention includes methods of diagnosing Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis in a subject. Also, the invention provides methods of identifying substances for the treatment or prevention of Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis and kits using the binding proteins of the invention. | 08-28-2008 |
20110212097 | Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases - The invention provides a method for treating a medical condition, disease, or disorder mediated by a misfolded form of superoxide dismutase (SOD) in a subject in need of treatment. The method optionally comprises administering to the subject a composition comprising a pharmaceutically acceptable vehicle and an agent selected from (1) an exogenous antibody or fragment thereof that binds selectively to the misfolded form of SOD, and/or (2) an immunogen that elicits production of an endogenous antibody that binds selectively to the misfolded form of SOD, and/or (3) a nucleic acid sequence encoding (1) or (2). In certain embodiments, the invention provides methods of treating diseases such as Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis and macular degeneration, glaucoma, ischemia, cerebral infarction, myocardial infarction, atherosclerosis, multiple sclerosis, inflammatory bowel disease, ulcerative colitis, Crohn's disease or necrotizing enterocolitis using disease-specific epitopes, and compositions including these epitopes. The invention also provides antibodies that bind to monomeric or misfolded SOD1, and not on the molecular surface of native homodimeric SOD1. In addition, the invention includes methods of diagnosing Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis in a subject. Also, the invention provides methods of identifying substances for the treatment or prevention of Alzheimer's Disease, Parkinson's Disease or amyotrophic lateral sclerosis and kits using the binding proteins of the invention. | 09-01-2011 |
Jorn Ostermann, Hannover DE
Patent application number | Description | Published |
---|---|---|
20150264361 | METHOD FOR SCREEN CONTENT CODING - Coding of screen content includes identifying corresponding areas in one or more previously coded frames to code unchanged areas in current frames. An unchanged area in a current frame is coded by copying a corresponding area from a previously coded frame or several previously coded frames. Usage of a copy mode to be applied to the unchanged areas is signaled in an encoding bitstream. The copy mode can be signaled for each unchanged area or a single copy mode is signaled for a group of unchanged areas. The copy mode can be automatically applied to one or more unchanged areas contiguous to the group of unchanged areas without further signaling the copy mode. Copying the corresponding area from the previously coded frame includes copying palette entries from the previously coded frame. Palette entries copied from the previously coded frame are reordered according to frequency of appearance. | 09-17-2015 |
Jorn Ostermann, Osnabruck DE
Patent application number | Description | Published |
---|---|---|
20100150232 | METHOD FOR CONCEALING A PACKET LOSS - A method of concealing a packet loss during video decoding is provided. An input stream having a plurality of network abstraction layer units NAL is received. A loss of a network abstraction layer unit in a group of pictures in the input stream is detected. A valid network abstraction layer unit order from the available network abstraction layer units is outputted. The network abstraction layer unit order is received by a video coding layer (VCL) and data is outputted. | 06-17-2010 |
Jörn Ostermann, Hannover DE
Patent application number | Description | Published |
---|---|---|
20120262444 | SCALABLE COMPRESSION OF TIME-CONSISTEND 3D MESH SEQUENCES - We present a method for predictive compression of time-consistent 3D mesh sequences supporting and exploiting scalability. The applied method decomposes each frame of a mesh sequence in layers, which provides a time-consistent multi-resolution representation. Following the predictive coding paradigm, local temporal and spatial dependencies between layers and frames are exploited for layer-wise compression. Prediction is performed vertex-wise from coarse to fine layers exploiting the motion of already encoded neighboring vertices for prediction of the current vertex location. Consequently, successive layer-wise decoding allows to reconstruct frames with increasing levels of detail. | 10-18-2012 |
Kai Ostermann, Dresden DE
Patent application number | Description | Published |
---|---|---|
20090215079 | Method and Devices for the Detection of Microorganisms and/or the Activity Thereof - In a method for detection of microorganisms and/or their activity with biosensors, on a surface of a substrate over portions thereof at least one ligand for binding a receptor or at least one receptor for a ligand or at least one ligand for binding a receptor and at least one receptor for either the one or a further ligand are immobilized chemically, physically, or biologically, wherein physical or physicochemical changes, caused at receptors by binding of ligands that are emitted by microorganisms in the process of quorum sensing are measured. | 08-27-2009 |
20100221817 | Whole-Cell Sensor - The invention relates to whole-cell sensors for monitoring bioavailable nitrogen, phosphorus and sulphur, individually or in at least one combination in a medium, and to the use thereof. The whole-cell sensors consist of genetically modified yeast cells which are immobilised in a xerogel matrix and contain at least one marker gene controlled by a promoter of a gene, the transcription of said gene being significantly increased or reduced in the absence of nitrogen, phosphorus or sulphur, and the yeast cells are at least coupled to a signal detector. | 09-02-2010 |
20100285505 | Device and Method for Detecting a Substance by Means of Particle Plasmon Resonance (PPR) or Particle-Mediated Fluorescence Based on Cell Surface Polarizations - The invention relates to devices and methods for detecting a substance by cell surface polarizations and the detection thereof by means of PPR or particle-mediated fluorescence. The device for detecting a substance by cell surface polarization according to the invention has cells, wherein a gene the expression of which leads to the polarized presentation of a protein on the surface of the cell is placed under the control of a promotor which can be regulated by the substance to be detected, nanoparticles which are functionalized with a molecule which can bind specifically to the surface-exposed protein, and at least one optical measurement device, such that an accumulation of the nanoparticles on the surface of the cells can be detected by particle plasmon resonance or particle-mediated fluorescence. | 11-11-2010 |
20110189657 | Device and a Method for the Detection and Amplification of a Signal - The invention relates to a device and a method for the detection and amplification of a primary signal, utilizing an intracellular communication system, and the use thereof for the detection of substances such as phosphorus, sulfur, nitrogen, hormones, metabolic intermediates, fermentation products, and so forth. The device according to the invention for the detection and amplification of a primary signal contains cells of a first type for which a gene, which is responsible for the synthesis of a signal molecule, is under the control of a promoter which is regulated by the primary signal, and cells of a second type for which a specific gene is under the control of a promoter which is regulated by the separated signal molecule, in such a way that the secretion of the signal molecule is induced by a primary signal taken up by a cell of the first type, and the primary signal is amplified by the cells of the second type by the expression of the specific gene under the control of the signal molecule. | 08-04-2011 |
20110256579 | Method for Verifying and/or Identifying Hormonally Effective Substances - The invention relates to a method for verifying and/or identifying hormonally effective substances using the pheromone system of yeast, to yeast cells for carrying out the method, and to the use thereof. The method according to the invention comprises the following steps: a) adding yeast culture medium or buffer to a sample which presumably contains a hormonally effective substance, b) thereafter contacting the sample with haploid yeast cells that possess features 1 through 3: 1. the DNA sequence coded for a heterologous hormone receptor is placed under the control of a constitutive promoter, 2. the DNA sequence coded for a yeast pheromone is placed under the control of a promoter that can be regulated by the hormone receptor, 3. a gene that is coded for a receptor for the yeast pheromone is constitutively expressed, wherein the activation of the hormone receptor by the hormonally effective substance leads to the expression and secretion of the yeast pheromone, and c) the physiological and/or morphological changes of haploid yeast cells are detected. | 10-20-2011 |
20140255712 | Method for coating substrates with at least one monolayer of self-assembling proteins - The invention relates to methods for coating a substrate with at least one monolayer of self-assembling proteins, using stabilized aqueous solutions with self-assembling proteins, and also to substrates obtainable as a result. Methods for stabilizing solutions with self-assembling proteins, and the stabilized solutions obtainable therefrom, are likewise provided by the invention. According to the coating method, at least one monolayer of a self-assembling protein is produced on a substrate by first providing a stabilized aqueous solution which comprises at least one self-assembling protein. To provide the coating solution, protein units aggregated from an aqueous solution of self-assembling proteins are separated off, and addition of a solution of ionic surfactants and/or of a salt-containing and/or alkaline and/or acidic solution to the protein-containing coating solution generates monomers or oligomers of the self-assembling proteins, and stabilizes them, the amount of ionic surfactant added being such that only the surface-active part of each active protein monomer or predominant protein oligomer is enveloped by surfactant particles. A substrate surface is then brought into contact with the stabilized, protein-containing solution, thus producing a protein-containing coating on the substrate. The supernatant solution is removed from the coated substrate and/or the coated substrate is dried. | 09-11-2014 |
Mathieu Ostermann, Saverne FR
Patent application number | Description | Published |
---|---|---|
20090257838 | Tool holder provided with a damping means - The present invention relates to a tool holder, such as a reaming head ( | 10-15-2009 |
Mathieu Ostermann, Allenwiller FR
Patent application number | Description | Published |
---|---|---|
20110318130 | Tool Holder Such as a Boring Head, a Chuck, or a Milling Cutting Arbor Integrating a Damping Device - A damping tool holder, such as a boring head, a chuck, or a milling cutting arbor, integrates a damping device ( | 12-29-2011 |
20150290718 | ASSEMBLY FOR TIGHTENING AND SECURING MALE AND FEMAILE PARTS FITTED TOGETHER - An assembly for tightening and securing includes a first male part and a second female part fitted together, which have complementary forms. The fitting includes at least one contact surface of the first part with the second part. The assembly also includes at least one annular means mounted on the periphery of one of the two parts. The annular means is connected in a translational manner to the part on which the annular means is mounted when the annular means abuts with the part on which the means is mounted, and arranged to interact with a peripheral surface of the complementary part during a rotation of the annular means in relation to the complementary part. | 10-15-2015 |
Matthieu Ostermann, Allenwiller FR
Patent application number | Description | Published |
---|---|---|
20110318127 | Tool Holder Equipped with a Damping Means and Comprising a Device for Preventing Excessive Heating of the Damping Means - A tool holder ( | 12-29-2011 |
Neil A. Ostermann, Humble, TX US
Patent application number | Description | Published |
---|---|---|
20150285017 | DOWNHOLE TOOL STRING BRAKING - A braking apparatus for a tool string positionable in a wellbore and a method of braking a tool string in a wellbore is disclosed. The braking apparatus includes: a tubular housing having at least one radial arm-bay opening; an actuating mechanism including: a wedge member mounted in an internal cavity of the housing; an axial guide rod coupled at one end to the wedge member; and a push-pull device. The push pull device includes: a biasing member casing through which the guide rod extends to contact the wedge member, a biasing member; and at least one braking arm pivotably mounted to a lower portion of the biasing member casing, wherein when the biasing member casing of the push-pull device in in a lowered position, the braking arm bears on a sloped surface of the wedge member to project the braking arm into contact with a wellbore wall. | 10-08-2015 |
Nils Ostermann, Basel CH
Patent application number | Description | Published |
---|---|---|
20110263560 | Organic Compounds - 3,4-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,4-substituted piperidine compound, and/or a method of treatment comprising administering a 3,4substituted piperidine compound, a method for the manufacture of a 3,4-substituted piperidine compound, and novel intermediates and partial steps for their synthesis are disclosed. The 3,4-disubstituted piperidine compounds have the formula (I), wherein the symbols have the meanings defined in the specification. | 10-27-2011 |
20130028843 | KALLIKREIN 7 MODULATORS - The present invention relates to the crystal structure of the serine protease kallikrein 7 and to the use of this crystal structure in drug discovery. The present invention also relates to compounds binding specifically to this active site of kallikrein 7. | 01-31-2013 |
Peter Ostermann, Bocholt DE
Patent application number | Description | Published |
---|---|---|
20090276050 | SPACE KEEPER WITH ADJUSTABLE AXIAL LENGTH - A space keeper for insertion between two vertebrae which has a variable axial length is provided. The space keeper possesses a sleeve-like first member ( | 11-05-2009 |
Philippe Ostermann, Dijon FR
Patent application number | Description | Published |
---|---|---|
20150195994 | Agricultural Baler and Method - An agricultural round baler is described. The agricultural round baler comprises a holding and supplying device for crops, a pressing chamber with pressing elements for pressing the crops, and a wrapping or binding device for the wrapping or binding of a pressed round bale. In order to design a round bale production which is, as a whole, more productive, the proposal is made that it be possible for at least the pressing elements to be operated, during a wrapping or binding operation following a pressing operation, at a higher running speed than the speed during the pressing operation. | 07-16-2015 |
Rainer Ostermann, Luwigshafen DE
Patent application number | Description | Published |
---|---|---|
20140364524 | METHOD FOR PRODUCING EXPANDABLE STYRENE POLYMERS CONTAINING GRAPHITE AND FLAME RETARDANT - A process for producing expandable styrene polymers via polymerization of at least one vinylaromatic monomer in aqueous suspension in the presence of at least one halogenated polymer as flame retardant, graphite, and blowing agent, which comprises the presence, in the aqueous suspension at the start of the polymerization reaction, of from 1 to 30% by weight of at least one styrene polymer, based on the entirety of monomers and styrene polymer, and likewise the presence of at least one halogenated polymer as flame retardant in the styrene polymer used at the start of the polymerization reaction. | 12-11-2014 |
Rainer Ostermann, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20120172467 | FLAME RETARDANT SYSTEM - The invention relates to a flame retardant comprising | 07-05-2012 |
20150322182 | HIGH-TEMPERATURE PEROXIDE-CONTAINING STYRENE POLYMER BEADS FOR SEED POLYMERIZATION - Styrene beads, wherein the styrene polymer beads comprise from 0.5 to 5% by weight of one or more high-temperature peroxides, where the high-temperature peroxides have a half-life time of 1 hour in the range from 110 to 160° C., measured in cumene. | 11-12-2015 |
Rainer Ostermann, Hemer DE
Patent application number | Description | Published |
---|---|---|
20120217681 | PROCESS FOR PRODUCING NANOFIBRES - The present invention relates to a process for producing metal oxide nanofibers using a sol-gel precursor. The nanofibers produced by the process according to the invention are notable for an increased metal oxide content compared to the prior art. | 08-30-2012 |
Thomas Ostermann, Velden / Woerthersee AT
Patent application number | Description | Published |
---|---|---|
20150069394 | Semiconductor Device and Method for Manufacturing a Semiconductor Device - A device includes a semiconductor chip. An outline of a frontside of the semiconductor chip includes at least one of a polygonal line including two line segments joined together at an inner angle of greater than 90° and an arc-shaped line. | 03-12-2015 |
Thomas Ostermann, Oberwinklern AT
Patent application number | Description | Published |
---|---|---|
20100207206 | TRANSISTOR - A transistor has a cell array with two or more transistor cells, a temperature sensor, which is integrated in the cell array or is adjacent to the cell array, and an isolation structure. The isolation structure isolates the temperature sensor from the cell array, and has an isolation trench, which is arranged between the cell array and the temperature sensor. The distance between the temperature sensor and the active transistor cell that is closest to the temperature sensor corresponds approximately to the pitch between active transistor cells within the cell array. | 08-19-2010 |
Thomas Ostermann, Koestenberg AT
Patent application number | Description | Published |
---|---|---|
20090032906 | ELECTRO STATIC DISCHARGE DEVICE AND METHOD FOR MANUFACTURING AN ELECTRO STATIC DISCHARGE DEVICE - An electro static discharge device includes a semiconductor body. The semiconductor body includes a first surface, a first semiconductor region of a first conductivity type, a second semiconductor region of a second conductivity type arranged on the first semiconductor region and a third semiconductor region of the first conductivity type. The third semiconductor region is isolated from the first semiconductor region by the second semiconductor region. A resistor structure is arranged in the semiconductor body and comprises at least one trench structure. The resistor structure is arranged at least in the second semiconductor region and provides a high-resistance electrical connection between a first portion and a second portion of the second semiconductor region. | 02-05-2009 |
20120133024 | Semiconductor Device and Method for Manufacturing a Semiconductor Device - According to an embodiment, a method for manufacturing a semiconductor device is provided. The method includes providing a mask layer which is used as an implantation mask when forming a doping region and which is used as an etching mask when forming an opening and a contact element formed in the opening. The contact element is in contact with the doping region. | 05-31-2012 |
20140210052 | Semiconductor Device and Method for Manufacturing a Semiconductor Device - According to an embodiment, a method for manufacturing a semiconductor device is provided. The method includes providing a mask layer which is used as an implantation mask when forming a doping region and which is used as an etching mask when forming an opening and a contact element formed in the opening. The contact element is in contact with the doping region. | 07-31-2014 |
Thomas Ostermann, Velden Am Woerthersee AT
Patent application number | Description | Published |
---|---|---|
20160139077 | Apparatus for Analyzing Ion Kinetics in Dielectrics - An apparatus for analyzing ion kinetics in a dielectric probe structure includes an ion reservoir abutting the dielectric probe structure and configured to supply mobile ions to the dielectric probe structure, a capacitor structure configured to generate an electric field in the dielectric probe structure along a vertical direction, and an electrode structure configured to generate an electrophoretic force on mobile ions in the dielectric probe structure along a lateral direction. A method for analyzing ion kinetics in the dielectric probe structure of the apparatus is also provided. | 05-19-2016 |
Thomas Krotscheck Ostermann, Koestenberg AT
Patent application number | Description | Published |
---|---|---|
20140061677 | Opto-Electronic Sensor - Some embodiments of the present disclosure relate to an infrared (IR) opto-electronic sensor having a silicon waveguide implemented on a single silicon integrated chip. The IR sensor has a semiconductor substrate having a silicon waveguide extends along a length between a radiation input conduit and a radiation output conduit. The radiation input conduit couples radiation into the silicon waveguide, while the radiation output conduit couples radiation out from the silicon waveguide. The silicon waveguide conveys the IR radiation from the radiation input conduit to the radiation output conduit at a single mode. As the radiation is conveyed by the silicon waveguide, an evanescent field is formed that extends outward from the silicon waveguide to interact with a sample positioned between the radiation input conduit and the radiation output conduit. | 03-06-2014 |
20150123131 | Semiconductor Devices and Methods of Formation Thereof - In one embodiment, a semiconductor device includes a first contact pad disposed at a top side of a workpiece, a second contact pad disposed at the top side of the workpiece. An isolation region is disposed between the first contact pad and the second contact pad. A metal strip is disposed at least partially within the isolation region. The metal strip is not coupled to an external potential node. | 05-07-2015 |
20150362672 | LIQUID SENSING SYSTEMS AND METHODS USING A RING RESONATOR SENSOR - A sensor system having a multi-pass interaction region is disclosed. The system includes an input region, a multi-pass region, and an output region. The input region is configured to receive emitted light. The multi-pass region is coupled to the input region and is configured to absorb portions of the emitted light according to a specimen proximate the multi-pass region. The output region is coupled to the multi-pass region and is configured to provide interacted light from the multi-pass region. | 12-17-2015 |
Ulf Ostermann, Rumpel DE
Patent application number | Description | Published |
---|---|---|
20150020569 | TEST STATION FOR PORTABLE GAS MEASURING DEVICES - A test station for a plurality of test gases, includes a main unit ( | 01-22-2015 |
20150106033 | METHOD FOR OPERATING A GAS CONCENTRATION MONITORING SYSTEM, GAS-MEASURING DEVICE, CENTRAL UNIT, GAS CONCENTRATION MONITORING SYSTEM AS WELL AS COMPUTER PROGRAM PRODUCT - A method is provided for operating a gas concentration monitoring system as well as a gas-measuring device, a central unit, a gas concentration monitoring system as well as computer program product. The safety of persons or the safety of a situation is determined with respect to at least one hazardous gas. The concentration of the gas is provided to a memory and analysis device. A measured value rating number is determined for a preset period of use. A number of instances, of the measured concentration values exceeding of a preset gas concentration limit value is input. A safety code is determined from at least one of: the measured concentration values, the measured value rating numbers and from the a total number of instances in which a gas concentration limit value was exceeded. | 04-16-2015 |